Transdermal and Transmucosal Drug Delivery Systems Market key players 2017-2025 : Aveva Drug Delivery Systems, 3M Pharmaceuticals, DURECT Corporation, ALZA Corporation, and TEVA Pharmaceutical Industries Ltd
Transdermal drug delivery systems (TDDS) generally known as patches, are the systems use intact skin, as a mean of administering drug into the circulation system of the body. A transdermal patch is a free separate dose form which when applied on the skin, transports the medication at a precise and organized rate. The first transdermal system was approved by the FDA in 1979 for the treatment of vomiting and nausea. There are several benefits associated with transdermal and transmucosal drug delivery systems such as they evade first pass effect, decrease multiple dosage, avoid chemically unfriendly GI environment, improve patient compliance, permit use of drugs with short shelf life, provide a controlled release of very potent drugs and drug input can be easily interrupted when toxicity occurs.
Request Sample Copy of the Report @
This industry research report is a brief review of the growth trail in terms of current, historical, and future scenarios of the global transdermal and transmucosal drug delivery systems market. It offers an evaluation of the aspects that are expected to influence the development of the market and the primary trends have also been specified in the research study. The research study also offers a broad lookout on the vendor landscape of the market through Porter’s five forces analysis. The research publication provides references of mergers and acquisitions, the research and development activities, specifics on licensing and collaborations. The report probes into the strategies related to marketing, shares, and product portfolio of the key participants in the global transdermal and transmucosal drug delivery systems market.
Global Transdermal and Transmucosal Drug Delivery Systems Market: Emerging Trends
The transdermal and transmucosal drug delivery systems market is exhibiting a commendable growth owing to the high incidence rate of chronic diseases such as diabetes and hypertension. Moreover, ghoulish lifestyle practices, extreme alcohol consumption, and the consumption of drugs such as amphetamines and cocaine among people are the chief factors triggering heart disease, further augmenting the growth of transdermal and transmucosal drug delivery systems market. However, an upsurge in overall healthcare expenditure, severe regulatory policies, and high costs of clinical trials are some of the factors are likely to impede the growth of TDDS system. Presently, transdermal and transmucosal drug delivery systems market is an extremely fragmented and reputed market owing to the participation of many recognized as well as emerging players in the industry.
Request TOC of the Report @
Global Transdermal and Transmucosal Drug Delivery Systems Market: Regional Analysis
Geographically, North America is the leading market for transdermal and transmucosal drug delivery systems owing to the high incidence rate of cardiac diseases along with the increasing base of brain disorder patients. A sizeable number of such patients are expected to drive the market growth for transdermal and transmucosal drug delivery systems. However, other regions such as South East Asia, Middle East and Latin America are also projected to be the prospective markets in the future for vendors.
Global Transdermal and Transmucosal Drug Delivery Systems Market: Vendor Landscape
Some of key participants in the market are Medipatch, Inc., Aveva Drug Delivery Systems, 3M Pharmaceuticals, DURECT Corporation, ALZA Corporation, and TEVA Pharmaceutical Industries Ltd.
About TMR Research
TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.
3739 Balboa St # 1097,
San Francisco, CA 94121
This release was published on openPR.
Permanent link to this press release:
You can edit or delete your press release Transdermal and Transmucosal Drug Delivery Systems Market key players 2017-2025 : Aveva Drug Delivery Systems, 3M Pharmaceuticals, DURECT Corporation, ALZA Corporation, and TEVA Pharmaceutical Industries Ltd here
News-ID: 1681310 • Views: 707
More Releases from TMR Research
KEY OPINION LEADER MANAGEMENT MARKET SCOPE, SEGMENTATION, DEVELOPMENT AND OPPORT …
Global Key Opinion Leader Management Market: Snapshot Key opinion leaders (KOLs) are trustworthy, influential, and experts of a particular field in the healthcare industry. Relationships of a firm with these KOLs is of great importance to manage and build a strong healthcare profile. These key opinion leaders go a long way towards educating the scientific and medical communities as well as help in increasing awareness pertaining to the recent developments in
SMART WATER GRID MARKET NEWER SEGMENTS OF APPLICATION 2025
Global Smart Water Grid Market – Snapshot The global smart water grid market is foreseen to experience its development prodded on the back of the prerequisite of managing old infrastructure, rise in information and communication technology (ICT), gap between supply and demand, water shortage, and several other factors. So as to guarantee smooth supply of water and keep a tab on its equal supply, smart water grid technology is expected to
DIGITAL UTILITY MARKET EXPANSION PROJECTED TO GAIN AN UPTICK DURING 2025
Global Digital Utility Market: Snapshot In the midst of surging demand for quick digitalization and green energy in the energy segment, the interest for digital utility system is rising notably. Penetration of digital innovations in the vitality sector and programs in nations, for example, India and China expected to fulfil local needs are foreseen to feed the demand for digital utility solutions. Get Exclusive PDF Sample Copy Of This Report: https://www.tmrresearch.com/sample/sample?flag=B&rep_id=3398 Rise in
WEB CONTENT MANAGEMENT MARKET VALUE PROJECTED TO EXPAND BY 2025
Global Web Content Management Market: Snapshot The global web content management market is anticipated to gain impetus due to the need for organizing and appropriately using content across various marketing channels such as social media and mobile, and not just the web. Web content management allows users to have a seamless web experience while helping organizations to digitally market their products and services. It helps both technical and non-technical users to
More Releases for Transdermal
Fentanyl Transdermal Patches Market – Comprehensive Survey 2025
This research study is one of the most detailed and accurate ones that solely focus on the global Fentanyl Transdermal Patches market. It sheds light on critical factors that impact the growth of the global Fentanyl Transdermal Patches market on several fronts. Market participants can use the report to gain sound understanding of the competitive landscape and strategies adopted by leading players of the global Fentanyl Transdermal Patches market. The
Transdermal Patch Market Report 2018: Segmentation by Product (Fentanyl Transder …
Global Transdermal Patch market research report provides company profile for Actavis, Mundipharma, Henan Lingrui Pharmaceutical, Changzhou Siyao, Rfl Pharmaceutical, Hisamitsu Pharmaceutical, Novartis, Johnson & Johnson, Teikoku Pharma, Mylan and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018
Transdermal Scopolamine Market Evolution / Developments
A new study by Transparency Market Research (TMR) indicates that Novartis AG, alone, contributed nearly 41.0% of the overall revenue of the global transdermal scopolamine market in 2016. Other two torch bearers in the market, namely, GlaxoSmithKline Plc and Baxter International Inc., commanded a cumulative share of 49.0% in the same year. Even though, the number of small players in the market is less, the degree of competition within the
US Transdermal Patch Market US Transdermal Sales Report 2020
For Report Sample Contact: firstname.lastname@example.org or +91-11-47067990 Report Table of Contents 1. Introduction to Transdermal Patch 2. Classification of Transdermal Patches 2.1 Single/ Multiple-Layer Drug-in-Adhesive 2.2 Reservoir Transdermal Patches 2.3 Matrix Based Transdermal Patches 2.4 Vapor Patch 2.5 Active and Passive Patch 3. Why There Exist Need for Transdermal Patches? 4. Mechanism of Transdermal Patch Drug Delivery 4.1 Properties of Transdermal Therapeutics 4.2 Components of
Transdermal Patch Market Transdermal Patch Clinical Pipeline Report 2022
For Report Sample Contact: email@example.com or +91-11-47067990 Report Table of Contents Introduction to Transdermal Patch Classification of Transdermal Patches 2.1 Single/ Multiple-Layer Drug-in-Adhesive 2.2 Reservoir Transdermal Patches 2.3 Matrix Based Transdermal Patches 2.4 Vapor Patch 2.5 Active and Passive Patch Why There Exist Need for Transdermal Patches? Mechanism of Transdermal Patch Drug Delivery 4.1 Properties of Transdermal Therapeutics 4.2 Components of Transdermal Patch 4.3
Transdermal Drug Delivery Market & Clinical Pipeline Insight
Transdermal drug delivery system, over the past decades, has emerged as a major tool for treating diseases of the skin. The major underlying factor driving this method is that the human skin is the most readily accessible surface for the delivery of drugs. A transdermal patch is defined as a medicated adhesive patch which is placed on the skin for delivering a specific dose of medication through the layers of